XIST lost induces ovarian cancer stem cells to acquire taxol resistance via a KMT2C-dependent way

Ruili Huang1, Lijuan Zhu1, Yali Zhang1

  • 1Department of Gynaecology and Obstetrics, The First People's Hospital of Shangqiu, Henan, No. 292 Kaixuan South Road, 476100 Shangqiu, Henan People's Republic of China.

Cancer Cell International
|September 18, 2020
PubMed
Abstract

Insights

Long non-coding RNA XIST enhances paclitaxel sensitivity in ovarian cancer by regulating KMT2C stability, impacting tumor stem cells. This study clarifies XIST

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Long non-coding RNA XIST expression is linked to paclitaxel sensitivity in ovarian cancer.
  • The precise mechanism by which XIST influences ovarian cancer stem cells and drug response remains unclear.

Purpose of the Study:

  • To investigate the role of XIST in regulating ovarian cancer stem cells.
  • To elucidate the mechanism of XIST action on paclitaxel sensitivity in ovarian cancer.

Main Methods:

  • Sphere assays, FACS, and MTT assays were used to assess cancer stem cell populations and proliferation.
  • Luciferase reporter assays and RT-qPCR validated the interaction between XIST, miR-93-5p, and KMT2C.
  • In vivo experiments in nude mice evaluated tumor growth and response to paclitaxel.

Main Results:

  • XIST expression inversely correlated with the cancer stem cell population (CD44+/CD24-).
  • XIST enhances KMT2C mRNA stability, promoting histone methylation and affecting cancer stem cell proliferation.
  • XIST targets miR-93-5p to regulate KMT2C, thereby influencing paclitaxel resistance in ovarian cancer.

Conclusions:

  • XIST promotes paclitaxel sensitivity in ovarian cancer stem cells through a KMT2C-dependent pathway.
  • Understanding the XIST/miR-93-5p/KMT2C axis offers potential therapeutic targets for improving ovarian cancer treatment.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.1K